Sign Up to like & get
recommendations!
1
Published in 2021 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyab031
Abstract: BACKGROUND Stage III melanoma is a heterogenous disease, and the number of tumor-involved lymph nodes is the most significantly unfavorable prognostic indicator for relapse and outcome. The aim of this study is to investigate the…
read more here.
Keywords:
stage iii;
mitotic rate;
node positive;
positive stage ... See more keywords